Fosifloxuridine nafalbenamide

DB14859InvestigationalSmall molecule

Fosifloxuridine nafalbenamide is under investigation in clinical trial NCT03428958 (A Safety Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment).

Chemical structure of Fosifloxuridine nafalbenamide
Formula / weight
C29H29FN3O9P · 613.535 g/mol (avg)
Code names
NUC-3373

Resolves to

Compound
UNII4YO6QT3SZ9CAS1332837-31-6ChEMBLCHEMBL2181367
Structure
InChIKeyBIOWRMNRHMERIO-ZVAHOJSLSA-NSMILESC[C@H](NP(=O)(OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(F)C(=O)NC1=O)OC1=C2C=CC=CC2=CC=C1)C(=O)OCC1=CC=CC=C1
Targets
P04818TYMS

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Fosifloxuridine nafalbenamide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In